NEW YORK (GenomeWeb News) — Invitrogen said Wednesday that its second-quarter revenue climbed 13 percent as R&D spending rose 11 percent and net income was up 108 percent.
 
Total receipts for the three months ended June 30, 2007 rose to $321.7 million from $285.4 million year over year.
 
Invitrogen’s Biodiscovery sales rose 10 percent to $223 million for the second quarter, while its Cell Culture Systems division saw revenue rise 20 percent to $99 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.